SCHEMBL2549645

SCHEMBL2549645

CCCC(O)O[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23375395 0.84 GPR84 (0.42)
SCHEMBL3649473 0.81
SCHEMBL2548853 0.78 TSHR (0.36)
SCHEMBL10629231 0.77
SCHEMBL3286639 0.74
SCHEMBL887050 0.73
SCHEMBL28530851 0.73 TSHR (0.38)
SCHEMBL1829156 0.73
SCHEMBL8277384 0.73 ALDH1A1 (0.34)
SCHEMBL28280677 0.73 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023142996-A1 METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT 上海岸阔医药科技有限公司 2023-08-03 WO claimed
CN-111601617-A Method for preventing or treating diseases related to EGFR inhibition 上海岸阔医药科技有限公司 2020-08-28 CN claimed
WO-2019201195-A1 METHOD FOR PREVENTING OR TREATING SIDE EFFECTS OF CANCER THERAPY 上海岸阔医药科技有限公司 2019-10-24 WO claimed
US-20250289809-A1 COMPOUNDS USEFUL FOR GOUT ATOM BIOSCIENCE AMERICA CORPORATION (US) 2025-09-18 US disclosed
US-20250270178-A1 METHODS OF PRODUCING A NITRATE ESTER NORTHROP GRUMMAN SYSTEMS CORPORATION 2025-08-28 US disclosed
US-20250170090-A1 METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT ONQUALITY PHARMACEUTICALS CHINA LTD (CN) 2025-05-29 US disclosed
CN-119613265-A Method for preparing omega-nitrooxy-1-alkanol 帝斯曼知识产权资产管理有限公司 2025-03-14 CN disclosed
EP-4516788-A1 COMPOUND CAPABLE OF BEING USED FOR GOUT Atom Therapeutics Co., Ltd (CN) 2025-03-05 EP disclosed
CN-119350280-A Nitric oxide donor type beraprost derivative, and pharmaceutical composition and application thereof 广州楷石医药有限公司 2025-01-24 CN disclosed
EP-4470565-A1 METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT OnQuality Pharmaceuticals China Ltd. (CN) 2024-12-04 EP disclosed
US-20240300935-A1 Nitrogen Oxide Donors of Beraprost Derivative and the Pharmaceutical Compositions with the Use Thereof GUANGZHOU KEMROCMED CO., LTD. (CN) 2024-09-12 US disclosed
US-20210212998-A1 Combinations of Tie-2 Activators and Prostaglandins and Uses Thereof EyePoint Pharmaceuticals, Inc. 2021-07-15 US disclosed
CN-112703179-A Method for preparing omega-nitrooxy-1-alkanol 帝斯曼知识产权资产管理有限公司 2021-04-23 CN disclosed
CN-111601617-A Method for preventing or treating diseases related to EGFR inhibition 上海岸阔医药科技有限公司 2020-08-28 CN disclosed
WO-2020053194-A1 PROCESS FOR THE MANUFACTURE OF OMEGA NITROOXY-1-ALKANOLS DSM IP ASSETS B.V. (NL) 2020-03-19 WO disclosed
US-10583111-B2 Method for preventing or treating diseases associated with the inhibition of EGFR ONQUALITY PHARMACEUTICALS CHINA LTD. (CN) 2020-03-10 US disclosed
US-20190282536-A1 METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH THE INHIBITION OF EGFR SHANGHAI JIAO TONG UNIVERSITY (CN) 2019-09-19 US disclosed
CN-103874488-B NO and H2S discharges compound 纽约城市大学研究基金会 2018-03-20 CN disclosed
CN-103874488-A NO- and H2S- releasing compounds UNIV CITY NEW YORK RES FOUND 2014-06-18 CN disclosed
WO-2011120695-A1 PROCESS FOR THE PRODUCTION OF ESTERS OF NITRIC ACID LONZA LTD (CH) 2011-10-06 WO disclosed